Dual T cell– and B cell–intrinsic deficiency in humans with biallelic RLTPR mutations

Abstract
Combined immunodeficiency (CID) refers to inborn errors of human T cells that also affect B cells because of the T cell deficit or an additional B cell–intrinsic deficit. In this study, we report six patients from three unrelated families with biallelic loss-of-function mutations in RLTPR, the mouse orthologue of which is essential for CD28 signaling. The patients have cutaneous and pulmonary allergy, as well as a variety of bacterial and fungal infectious diseases, including invasive tuberculosis and mucocutaneous candidiasis. Proportions of circulating regulatory T cells and memory CD4+ T cells are reduced. Their CD4+ T cells do not respond to CD28 stimulation. Their CD4+ T cells exhibit a "Th2" cell bias ex vivo and when cultured in vitro, contrasting with the paucity of "Th1," "Th17," and T follicular helper cells. The patients also display few memory B cells and poor antibody responses. This B cell phenotype does not result solely from the T cell deficiency, as the patients’ B cells fail to activate NF-κB upon B cell receptor (BCR) stimulation. Human RLTPR deficiency is a CID affecting at least the CD28-responsive pathway in T cells and the BCR-responsive pathway in B cells.
Funding Information
  • Institut National de la Santé et de la Recherche Médicale
  • Paris Descartes University
  • French National Research Agency (ANR-10-IAHU-01)
  • National Agency for Research on AIDS and Viral Hepatitis (ANRS-13292)
  • St. Giles Foundation
  • ANRS (n°13318)
  • National Institute of Allergy and Infectious Diseases (5T32AI007512)
  • ANRS (ANR-13-PDOC-0025-01)
  • National Health and Medical Research Council
  • Australian-American Fulbright Commission
  • National Institute of Allergy and Infectious Diseases (R01AI100887-01)